StockOtters
StockOttersSupply Chain Map
Huadong Medicine Co., Ltd logo

Huadong Medicine Co., Ltd

000963.SZ

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
5,867
Cost of Revenue
3,921
Gross Profit
1,946
Gross Margin
33.2%
Operating Income
605
Operating Margin
10.3%
Net Income
492
Net Margin
8.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
713
EBITDA Margin
12.1%

2023

12/31/2023

Revenue
5,687
Cost of Revenue
3,846
Gross Profit
1,842
Gross Margin
32.4%
Operating Income
483
Operating Margin
8.5%
Net Income
397
Net Margin
7.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
604
EBITDA Margin
10.6%

2022

12/31/2022

Revenue
5,280
Cost of Revenue
3,596
Gross Profit
1,684
Gross Margin
31.9%
Operating Income
429
Operating Margin
8.1%
Net Income
350
Net Margin
6.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
529
EBITDA Margin
10.0%

2021

12/31/2021

Revenue
4,839
Cost of Revenue
3,356
Gross Profit
1,483
Gross Margin
30.7%
Operating Income
400
Operating Margin
8.3%
Net Income
322
Net Margin
6.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
464
EBITDA Margin
9.6%

2020

12/31/2020

Revenue
4,716
Cost of Revenue
3,158
Gross Profit
1,558
Gross Margin
33.0%
Operating Income
487
Operating Margin
10.3%
Net Income
395
Net Margin
8.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
484
EBITDA Margin
10.3%